Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantA. MENARINI SINGAPORE PTE. LTD.
Licence HolderA. MENARINI SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification
Formulation Information
SYRUP
**Dosage** Adults and children above 12 years --- 2 x 5ml spoonfuls. Repeat 3 times a day.
ORAL
Medical Information
**Indication** Breacol is indicated as an expectorant for symptomatic relief of cough due to colds and upper respiratory tract infection.
R05CA03
guaifenesin
Manufacturer Information
A. MENARINI SINGAPORE PTE. LTD.
PHARMANIAGA MANUFACTURING BERHAD
PT. MENARINI INDRIA LABORATORIES
Active Ingredients
Documents
Patient Information Leaflets
2019MEN-0169-1 Breacol Cough Syrup Insert SG 12 June 2019.pdf
Approved: July 2, 2020